B
EXC icon

Bayban’s Exelon EXC Stock Holding History

Bayban’s Portfolio EXC Stock Details EXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.9K Buy
963
+100
+12% +$4.63K 0.03% 245
2026
Q1 		$42.3K Hold
863
– – 0.04% 246
2025
Q4 		$37.6K Buy
+863
New +$39.4K 0.03% 254

Other funds holding EXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayban's EXC Position: Q2 2026 in Review

Bayban increased its Exelon (EXC) stake by 12% in Q2 2026, buying an estimated $4.63K and bringing the position to 963 shares worth $44.9K. The position accounts for 0.03% of the portfolio, ranked #245.

Bayban first reported a position in EXC in Q4 2025 and has held it in 3 quarters since. 1,230 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Bayban held 963 shares of Exelon worth $44.9K as of Q2 2026.
  • Bayban bought 100 Exelon shares in Q2 2026, an estimated $4.63K.
  • Exelon made up 0.03% of Bayban's portfolio in Q2 2026, its #245 holding.
  • Bayban first reported a position in Exelon in Q4 2025 and has held it in 3 quarters since.
  • 1,230 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.